Synodos NF2

syn2343195

Created By Brian Bot BrianMBot

dataType: Analysis drugScreen geneExpression genomicVariants immunoassay kinomics volume
grantDOI: https://doi.org/10.48105/pc.gr.88541 https://doi.org/10.48105/pc.gr.88552 https://doi.org/10.48105/pc.gr.88580 https://doi.org/10.48105/pc.gr.88495 https://doi.org/10.48105/pc.gr.88438 https://doi.org/10.48105/pc.gr.88461 https://doi.org/10.48105/pc.gr.88567 https://doi.org/10.48105/pc.gr.88682 https://doi.org/10.48105/pc.gr.88823
studyName: Synodos NF2
dataStatus: Available
initiative: Synodos
studyLeads: Jaishri Blakeley D. Wade Clapp James Gusella Scott Plotkin
studyStatus: Completed
diseaseFocus: Neurofibromatosis type 2
institutions: Johns Hopkins Medicine Indiana University Massachusetts General Hospital Harvard Medical School University of Central Florida FLI-Leibniz-Germany University of North Carolina Ohio State University Sage Bionetworks Children's Tumor Foundation
fundingAgency: CTF
manifestation: Schwannoma Meningioma
relatedStudies: syn27761862 syn51907739 syn26383473 syn22268652
studyFileviewId: syn11614200
HS01 vs HS11?
Welcome NF2 Community
syn18503377
syn6133098
syn55203921
syn54530846
syn11614200
syn10921791
syn6140303
syn6138288
syn6138291
syn59881315
syn51914478
syn51914129
syn21520573
syn19534577

Synodos NF2 page is loading…